Novavax
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $84,512 | $415,484 | $93,855 | $291,342 |
Gross Profit | 23,893 | 379,442 | 45,046 | 142,466 |
EBITDA | -105,396 | 179,861 | -129,030 | -161,790 |
EBIT | -118,096 | 168,729 | -141,177 | -172,584 |
Net Income | -121,300 | 162,381 | -147,550 | -178,389 |
Net Change In Cash | 84,512 | 415,484 | 93,855 | 291,342 |
Free Cash Flow | -145,564 | 311,144 | -90,805 | -185,859 |
Cash | 573,630 | 690,648 | 491,041 | 578,929 |
Basic Shares | 160,049 | 165,855 | 139,916 | 123,679 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $983,705 | $1,598,951 | $1,146,290 | $475,598 |
Gross Profit | 639,937 | 696,312 | 1,146,290 | 475,598 |
EBITDA | -487,390 | -604,713 | -1,673,915 | -411,834 |
EBIT | -528,615 | -633,767 | -1,686,576 | -416,719 |
Net Income | -545,062 | -657,939 | -1,743,751 | -427,505 |
Net Change In Cash | 983,705 | 1,598,951 | 1,146,290 | 475,598 |
Cost of Revenue | 884,813 | 564,443 | ||
Free Cash Flow | -772,773 | -508,922 | 265,460 | -97,163 |
Cash | 568,505 | 1,336,883 | 1,515,116 | 553,398 |
Basic Shares | 100,768 | 78,183 | 74,400 | 57,554 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.75 |
2024-06-30 | $0.99 |
2024-03-31 | -$1.05 |
2023-12-31 | -$1.44 |
